What is Global Aortic Endografts Market?
The Global Aortic Endografts Market is a vast and dynamic sector that plays a crucial role in the medical industry. It primarily revolves around the production, distribution, and use of aortic endografts, which are essentially stent grafts used in endovascular repair of aortic aneurysms. These devices are designed to reinforce the weakened section of the aorta, the largest artery in the body, to prevent it from rupturing. The market's value was estimated at US$ 2785 million in 2023, and it's projected to grow significantly in the coming years. The increasing prevalence of aortic aneurysms, advancements in technology, and the growing preference for minimally invasive procedures are some of the key factors driving this market.
Abdominal Aortic Endografts, Thoracic Aortic Endografts, Fenestrated and Branched Aortic Endografts, Flow Diverting Aortic Endografts in the Global Aortic Endografts Market:
The Global Aortic Endografts Market is segmented into various types, including Abdominal Aortic Endografts, Thoracic Aortic Endografts, Fenestrated and Branched Aortic Endografts, and Flow Diverting Aortic Endografts. Each type has its unique features and applications. Abdominal Aortic Endografts are used to treat abdominal aortic aneurysms, while Thoracic Aortic Endografts are used for thoracic aortic aneurysms. Fenestrated and Branched Aortic Endografts are advanced devices that allow for the treatment of complex aneurysms involving the renal and visceral arteries. Flow Diverting Aortic Endografts, on the other hand, are designed to divert blood flow away from the aneurysm, promoting thrombosis and eventual healing of the aneurysm.
Hospitals, Clinics, Others in the Global Aortic Endografts Market:
The usage of aortic endografts is widespread across various healthcare settings, including hospitals, clinics, and other medical facilities. In hospitals, these devices are commonly used in the surgical treatment of aortic aneurysms. They are preferred due to their minimally invasive nature, which results in less post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgery. Clinics also utilize these devices, particularly in outpatient settings where patients with smaller, less complex aneurysms are treated. Other uses of aortic endografts include research and development activities, teaching and training purposes, and in some cases, they are used in emergency situations to prevent aortic rupture.
Global Aortic Endografts Market Outlook:
Looking at the market outlook, the Global Aortic Endografts Market was valued at a substantial US$ 2785 million in 2023. The market is expected to witness a significant growth, reaching an estimated value of US$ 4447.2 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period from 2024 to 2030. This growth can be attributed to several factors, including the increasing prevalence of aortic aneurysms, advancements in endograft technology, and the growing preference for minimally invasive surgical procedures.
| Report Metric | Details |
| Report Name | Aortic Endografts Market |
| Accounted market size in 2023 | US$ 2785 million |
| Forecasted market size in 2030 | US$ 4447.2 million |
| CAGR | 6.9% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Cordis (Cardinal Health), Endologix, Inc., Endospan, Jotec, Lombard Medical Technologies Plc, Medtronic Plc, Microport Medical, Nano Endoluminal, Terumo Medical Corp., Transcatheter Technologies, TriVascular Inc., Vascutek, W. L. Gore and Associates |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
